Mesotron is developing the first non-invasive, continuous bedside platform for cerebral hemodynamic and neurometabolic coupling assessment. Our technology expands visibility of the brain in real time — enabling assessment of cerebral blood flow, oxygen metabolism, blood volume, vascular dynamics, cerebral autoregulation, and neurometabolic coupling through a single integrated platform.

​By unlocking real-time autoregulation to guide precision brain perfusion management, Mesotron helps clinicians better understand brain function during critical moments of care across neurocritical care, cardiac surgery, stroke, and neonatal applications. Trusted by leading hospitals worldwide, Mesotron is redefining brain monitoring through continuous functional insight at the bedside.